Laboratory

A new study led by researchers at UBC and the BC Centre for Excellence in HIV/AIDS (BC-CfE) is shedding light on how COVID-19 pandemic restrictions impacted another long-standing public health threat – HIV. The study, published in the Lancet Regional Health – Americas, examined HIV transmission during B.C.’s initial COVID-19 lockdown (March 22 to May […]

Infections caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant are common among individuals who have recovered from prior infection or have been vaccinated against the coronavirus disease 2019 (COVID-19). The Omicron has quickly overtaken the SARS-CoV-2 Delta variant as the dominant circulating strain globally. Currently, the original Omicron strain is

Moderna vaccine as a third dose produced especially strong responses People with undetectable HIV who received SARS-CoV-2 vaccines didn’t experience faster antibody declines than people without HIV after two vaccine doses and had equivalent or better antibody responses compared to a control group after a third dose, especially those who received the Moderna vaccine as

Dr Artem Babaian, a former post-doctoral student in medical genetics at the University of British Columbia (UBC) in Canada and now a Banting Fellow at the University of Cambridge in the United Kingdom, together with his mountain-climbing partner, Jeff Taylor, a UBC engineering student, knew that scientists had isolated 15,000 viruses that could infect humans,

Overall, vaccines are highly effective, but some folks are at risk for poorer response. Studies of COVID-19 outcomes among people living with HIV have yielded conflicting results, but some show that HIV-positive people are at greater risk for severe illness and death. Many people with HIV are older and have other chronic health conditions, and